166 Recruiting Glioblastoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
๐ Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Glioblastoma
Related Conditions
Top Recruiting Glioblastoma Studies
Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma
๐ Medical College of Wisconsin โ Milwaukee, Wisconsin
View Study & Checklist โA Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
๐ Col Uni Med Center New York Presby โ New York, New York
View Study & Checklist โA Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
๐ University of California, San Francisco โ San Francisco, California
View Study & Checklist โTrial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
๐ St. Joseph's Hospital and Medical Center โ Phoenix, Arizona
View Study & Checklist โA Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
๐ University of Alabama at Birmingham โ Birmingham, Alabama
View Study & Checklist โTesting the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
๐ Fairbanks Memorial Hospital โ Fairbanks, Alaska
View Study & Checklist โDC Migration Study to Evaluate TReg Depletion In GBM Patients With and Without Varlilumab
๐ Duke University Medical Center โ Durham, North Carolina
View Study & Checklist โPilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors
๐ Michigan State University/Sparrow Hospital โ East Lansing, Michigan
View Study & Checklist โN-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
๐ Chan Soon-Shiong Institute for Medicine (CSSIFM) โ El Segundo, California
View Study & Checklist โDose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
๐ University of Alabama at Birmingham Cancer Center โ Birmingham, Alabama
View Study & Checklist โImmunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
๐ University of Alabama at Birmingham, Children's of Alabama โ Birmingham, Alabama
View Study & Checklist โNivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
๐ Northwestern University โ Chicago, Illinois
View Study & Checklist โPembrolizumab and Standard Therapy in Treating Patients With Glioblastoma
๐ Mayo Clinic Hospital in Arizona โ Phoenix, Arizona
View Study & Checklist โOral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
๐ Froedtert Hospital & the Medical College of Wisconsin โ Milwaukee, Wisconsin
View Study & Checklist โA Study of Abemaciclib in Recurrent Glioblastoma
๐ University of California Los Angeles โ Los Angeles, California
View Study & Checklist โRadiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
๐ West Virginia University Cancer Institute Mary Babb Randolph Cancer Center โ Morgantown, West Virginia
View Study & Checklist โTemozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
๐ University of Alabama at Birmingham Cancer Center โ Birmingham, Alabama
View Study & Checklist โCART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
๐ University of Pennsylvania โ Philadelphia, Pennsylvania
View Study & Checklist โAnti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma
๐ Hospital of the University of Pennsylvania โ Philadelphia, Pennsylvania
View Study & Checklist โA Study With L19TNF in Combination With Lomustine in Patients With Glioblastoma at Progression or Recurrence
๐ Northwestern Memorial Hospital โ Chicago, Illinois
View Study & Checklist โStudy Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optuneยฎ) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
๐ University of Florida Health โ Gainesville, Florida
View Study & Checklist โA Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
๐ Department of Radiation Oncology at University of Iowa โ Iowa City, Iowa
View Study & Checklist โA Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma
๐ The University of Alabama at Birmingham Hospital โ Birmingham, Alabama
View Study & Checklist โAssessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI
๐ Froedtert Hospital & Medical College of Wisconsin โ Milwaukee, Wisconsin
View Study & Checklist โNivolumab With Radiation Therapy and Bevacizumab for Recurrent MGMT Methylated Glioblastoma
๐ Hartford Healthcare (Data Collection) โ Hartford, Connecticut
View Study & Checklist โPersonalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
๐ Massachusetts General Hospital โ Boston, Massachusetts
View Study & Checklist โSurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
๐ Massachusetts General Hospital Cancer Center โ Boston, Massachusetts
View Study & Checklist โMind-Body Intervention in Glioma Couples
๐ M D Anderson Cancer Center โ Houston, Texas
View Study & Checklist โSafety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
๐ Albert Einstein College of Medicine โ The Bronx, New York
View Study & Checklist โGammaTile and Stupp in Newly Diagnosed GBM
๐ HonorHeath Scottsdale Osborn Medical Center โ Scottsdale, Arizona
View Study & Checklist โMemory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma
๐ City of Hope Medical Center โ Duarte, California
View Study & Checklist โSurgical Nivolumab And Ipilimumab For Recurrent GBM
๐ University of California Los Angeles โ Los Angeles, California
View Study & Checklist โA Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous ฮณฮด T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma
๐ University of Alabama at Birmingham โ Birmingham, Alabama
View Study & Checklist โPhase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma
๐ M D Anderson Cancer Center โ Houston, Texas
View Study & Checklist โCART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
๐ University of Pennsylvania โ Philadelphia, Pennsylvania
View Study & Checklist โNivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM
๐ Dana-Farber Cancer Institute โ Boston, Massachusetts
View Study & Checklist โA Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
๐ Columbia University โ New York, New York
View Study & Checklist โAzeliragon in MGMT Unmethylated Glioblastoma
๐ University of Colorado Anschutz Medical Campus โ Aurora, Colorado
View Study & Checklist โAZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
๐ St. Joseph's Hospital and Medical Center โ Phoenix, Arizona
View Study & Checklist โMultiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
๐ University of Michigan Rogel Cancer Center โ Ann Arbor, Michigan
View Study & Checklist โ